posters

Clinical Implications of Resistance

Implications of lamivudine use and the M184V mutation in V118I-related multidrug resistance
BG Brenner

Determination of capravirine inhibitory quotient in HIV-infected, non-nucleoside reverse transcriptase inhibitor treatmentexperienced patients
AK Patick

Mutations in HIV-1 reverse transcriptase associated with hypersusceptibility to non-nucleoside reverse transcriptase inhibitors: impact on virological response to efavirenz-based salvage therapy
V Tozzi

High frequency of selection of the Q151M mutation in HIV-2- infected patients receiving nucleoside reverse transcriptase inhibitor-containing regimen
D Descamps

Resistance analysis of the benefit of a treatment interruption before salvage therapy including seven to nine antiretroviral drugs (GIGHAART ANRS 097)
C Delaugerre

Baseline resistance and predictors of virological response in the CPCRA 064 study: a randomized trial of structured treatment interruption for patients with multidrug-resistant HIV
J Lawrence

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy
MP Trotta